African American Study of Kidney Disease and Hypertension
Status:
Completed
Trial end date:
2007-06-30
Target enrollment:
Participant gender:
Summary
The AASK is a multicenter, randomized, controlled clinical trial using a 2 × 3 factorial
design to evaluate the effects of level of blood pressure control and type of
anti-hypertensive medication on progression of chronic renal disease among African American
men and women with chronic renal insufficiency caused by hypertension (hypertensive
nephrosclerosis).
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)